ALS

FDA faces backlash after seeking more data on an experimental ALS therapy
BioPharma Dive
Wed, 04/14/21 - 09:53 pm
ALS
AMX0035
Amylyx Pharmaceuticals
FDA
Ionis' Ups and Downs: Partnership with Progenity, 70% Job Cuts at Akcea and More
BioSpace
Wed, 04/7/21 - 07:15 pm
Ionis Pharmaceuticals
Progenity
ALS
clinical trials
FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
MedCity News
Thu, 03/4/21 - 09:53 am
BrainStorm Cell Therapeutics
ALS
stem cell therapy
clinical trials
FDA
Despite red flag from FDA, controversial ALS cell therapy developer says it may still march ahead anyway
Endpoints
Mon, 02/22/21 - 10:51 am
BrainStorm Cell Therapeutics
ALS
cell therapy
FDA
Stem cell therapy for ALS fails a large clinical trial
BioPharma Dive
Wed, 11/18/20 - 10:59 pm
ALS
clinical trials
stem cells
BrainStorm Therapeutics
Bristol Myers, insitro ally to apply machine learning to ALS R&D
Fierce Biotech
Wed, 10/28/20 - 10:35 am
Bristol-Myers Squibb
Insitro
machine learning
ALS
artificial intelligence
Early signs of survival benefit raise optimism around a small biotech's ALS drug
BioPharma Dive
Sun, 10/18/20 - 12:03 am
ALS
AMX0035
Amylyx Pharmaceuticals
Biogen teams up with gene-editing startup Scribe on ALS program
Pharmaforum
Thu, 10/8/20 - 11:09 am
Scribe Therapeutics
Biogen
ALS
CRISPR
Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines
Forbes
Tue, 10/6/20 - 11:16 pm
Jennifer Doudna
gene editing
Scribe Therapeutics
ALS
Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders
Xconomy
Wed, 09/23/20 - 11:19 pm
ALS
Libra Therapeutics
After a rare win, a biotech details long-awaited results for its ALS drug
BioPharma Dive
Wed, 09/2/20 - 07:54 pm
ALS
AMX0035
Amylyx
FDA
Biogen Shares Positive Data on Phase I/II Trial of Tofersen for SOD1-ALS
BioSpace
Sat, 07/11/20 - 11:45 am
Biogen
ALS
tofersen
BIIB067
clinical trials
Amylyx Pharmaceuticals nabs $30M for ALS, Alzheimer's work
Fierce Biotech
Thu, 07/2/20 - 11:11 am
Amylyx Pharmaceuticals
funding
ALS
Alzheimer's disease
Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases
BioSpace
Wed, 06/24/20 - 10:28 am
Yumanity Therapeutics
Merck
ALS
frontotemporal lobar dementia
R&D
After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug
BioSpace
Thu, 06/11/20 - 10:49 pm
Denali Therapeutics
Sanofi
DNL747
ALS
Alzheimer's disease
DNL788
clinical trials
Amgen-backed QurAlis Snags $42 Million in Series A to Develop ALS Treatments
BioSpace
Wed, 05/13/20 - 10:18 pm
Amgen
QurAlis
ALS
I Have a Dream… Five Dreams for Biotech
BioSpace
Mon, 01/20/20 - 11:03 am
biotech
patients
Alzheimer's disease
ALS
HIV
cancer
drug pricing
Alexion to Start Pivotal Study on Ultomiris for ALS in Q1
Yahoo/Zacks.com
Thu, 01/16/20 - 10:14 am
Alexion
ALS
Ultomiris
clinical trials
First-of-its-kind trial in ALS spurs hope for brutal disease
BioPharma Dive
Wed, 09/25/19 - 11:35 pm
ALS
clinical trials
Implicit Bioscience
Prilenia Therapeutics
Clene Nanomedicine
Ra Pharma
Biohaven
5 years later, Ice Bucket Challenge's impact on drug research still unfolding
Bizjournals
Fri, 08/2/19 - 10:49 am
ALS
fundraising
drug development

Pages